NDC 43825-200

Terlivaz

Terlipressin

Terlivaz is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mallinckrodt Hospital Products Inc.. The primary component is Terlipressin.

• Product ID: 43825-200_08efe631-e704-4997-a4f2-ac2131c051f1
• NDC: 43825-200
• Product Type: Human Prescription Drug
• Proprietary Name: Terlivaz
• Generic Name: Terlipressin
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-09-14
• Marketing Category: NDA /
• Application Number: NDA022231
• Labeler Name: Mallinckrodt Hospital Products Inc.
• Substance Name: TERLIPRESSIN
• Active Ingredient Strength: 1 mg/5mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 43825-200-01

1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) > 5 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2022-09-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details